Partner, Lux Capital
Life sciences and gene therapy investor
David Yang focuses on life sciences at Lux Capital, previously co-founding and serving as Head of Strategy & Operations at Latus Bio, a gene therapy company addressing neurological disorders. His academic background began at the Broad Institute developing viral diagnostic tools, with published research in Nature and Cell. He holds a degree from Harvard University.
Invest in entrepreneurs across therapeutics, R&D tools, and biopharma infrastructure, bridging computational and experimental biology.
Based in: San Francisco, CA (North America)